Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pravash Budhathoki

Showing results (61-70 of 63) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 63 results.
Research Square|March 30, 2023
Clinical Outcomes and Prognostic Factors in Triple-Negative Invasive Lobular Carcinoma of the BreastUtsav Joshi, Pravash Budhathoki, Suman Gaire, et al.
Breast Cancer Research and Treatment|May 20, 2023
Clinical outcomes and prognostic factors in triple-negative invasive lobular carcinoma of the breastUtsav Joshi, Pravash Budhathoki, Suman Gaire, et al.
Clinical Lung Cancer|January 16, 2026
Optimizing Tarlatamab Delivery in Small Cell and Neuroendocrine Lung Cancer: Real-World Insights into Step-Up Dosing and Prophylactic Tocilizumab UseUtsav Joshi, Faustine Ong, Daniel Melzer, et al.
Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
Research Square|March 30, 2023
Clinical Outcomes and Prognostic Factors in Triple-Negative Invasive Lobular Carcinoma of the BreastUtsav Joshi, Pravash Budhathoki, Suman Gaire, et al.
Breast Cancer Research and Treatment|May 20, 2023
Clinical outcomes and prognostic factors in triple-negative invasive lobular carcinoma of the breastUtsav Joshi, Pravash Budhathoki, Suman Gaire, et al.
Clinical Lung Cancer|January 16, 2026
Optimizing Tarlatamab Delivery in Small Cell and Neuroendocrine Lung Cancer: Real-World Insights into Step-Up Dosing and Prophylactic Tocilizumab UseUtsav Joshi, Faustine Ong, Daniel Melzer, et al.
Pageof 7